Retransition vs. detransition: what testosterone data actually shows
Quick answer
This creator stopped testosterone after approximately five years of use, reporting physical changes consistent with declining androgen levels, including softer skin and reduced facial hair density, while retaining permanent virilizing changes such as voice depth and altered fat distribution. Cessation of exogenous testosterone in individuals with ovaries may eventually restore endogenous hormonal cycling, but the timeline and completeness of that restoration vary by individual and duration of prior T use. Bone density monitoring and mental health support are clinically relevant considerations when discontinuing long-term testosterone therapy, and neither was mentioned in the video.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @artificialaugust actually say?
They announced stopping testosterone after five years, framing it not as detransition but as a personal evolution, what they call "retransition." They described physical changes after stopping T, including clearer skin and softer features, and made a specific factual claim: "medical transition has a lower regret rate than most medical procedures." They also said gender-affirming care "genuinely saved my life" and that it is "in no way dangerous or detrimental."
The video is personal testimony, and most of it is exactly that. But two claims cross into factual territory: the regret rate comparison and the blanket safety statement. Those deserve scrutiny, because they are being made to 183,000 viewers, some of whom may be making medical decisions.
Does the science back this up?
The regret rate claim is partially supported but presented too cleanly. The broader safety claim is more complicated than stated.
On regret: a systematic review by Bustos et al. (2021, Plastic and Reconstructive Surgery) found overall regret rates for gender-affirming surgeries around 1%, which is genuinely low. For comparison, regret rates for knee replacement surgery run 15-30% in some studies (Bourne et al., 2010, Clinical Orthopaedics). So the directional claim holds. However, regret research in this field has real methodological problems: high loss-to-follow-up rates, short follow-up windows, and changing diagnostic criteria over time. The WPATH-aligned literature acknowledges this.
On safety: testosterone therapy does carry documented risks, including polycythemia, lipid changes, and potential cardiovascular effects with long-term use (Irwig, 2017, Endocrinology and Metabolism Clinics of North America). Saying it is "in no way dangerous" is an overclaim. Gender-affirming care has a strong evidence base for improving psychological outcomes, but that is different from saying there are no risks.
What did they get wrong (or right)?
They got the regret rate directionally right. They got the framing of bodily autonomy and psychological benefit largely right, consistent with evidence from van der Miesen et al. (2018, Clinical Psychology Review) showing gender-affirming care improves quality of life and reduces dysphoria in most patients.
Where they overclaimed: "in no way dangerous or detrimental" is not accurate as a universal statement. Testosterone is a controlled medication with real physiologic effects. Stopping testosterone after five years also carries its own transition period, including the return of endogenous hormone cycles if ovarian function resumes, which can involve mood changes, cycle irregularities, and bone density considerations. The creator mentioned emotional difficulty when stopping but did not frame this clinically, which is fair for a personal video but worth naming here.
The word "retransition" versus "detransition" is a personal framing choice, not a medical one. Neither term is a clinical diagnosis. Both describe changes in gender expression or medical treatment. The creator is clear they are not trying to return to a prior identity, which is a valid and documented experience in the literature (Turban et al., 2021, JAMA Network Open).
What should you actually know?
If you are considering stopping testosterone or changing your hormone regimen, this video should not be your clinical guide. Here is what the evidence actually says.
- Stopping exogenous testosterone does not automatically restore prior hormonal baselines. Depending on duration of use and individual ovarian function, resumption of endogenous cycles varies significantly (Grimstad et al., 2021, Journal of Pediatric and Adolescent Gynecology).
- Some testosterone-induced changes, including voice deepening and clitoral growth, are largely permanent. Facial and body hair may thin but often does not fully reverse. This creator's experience of lighter facial hair is consistent with reported outcomes.
- Bone density is a real consideration. Long-term testosterone use followed by cessation without estrogen replacement may leave some individuals in a hormonal gap. A provider should assess this.
- The regret rate data, while genuinely low, comes from studies with limitations. It should inform your decision but not replace a conversation with a clinician who knows your history.
- Psychological support during hormone changes is not a weakness. The creator mentioned emotional difficulty. That is common and documented, and a mental health provider familiar with gender care is a reasonable resource.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 11 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Retransition vs. detransition: what testosterone data actually shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Comparison decision path
Use this comparison to narrow the provider review question
Direct answer
Retransition vs. detransition: what testosterone data actually shows should help you decide which option deserves a clinical review, not force a one-size answer.
Evidence check
A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.
Safety check
The right choice can change based on history, medication interactions, side effects, budget, and availability.
Next step
Compare available products and select the relevant treatment page for its specific next step.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
This creator stopped testosterone after approximately five years of use, reporting physical changes consistent with declining androgen levels, including softer skin and reduced facial hair density, while retaining permanent virilizing changes such as voice depth and altered fat distribution.
FormBlends verdict
This creator stopped testosterone after approximately five years of use, reporting physical changes consistent with declining androgen levels, including softer skin and reduced facial hair density, while retaining permanent virilizing changes such as voice depth and altered fat distribution. Cessation of exogenous testosterone in individuals with ovaries may eventually restore endogenous hormonal cycling, but the timeline and completeness of that restoration vary by individual and duration of prior T use. Bone density monitoring and mental health support are clinically relevant considerations when discontinuing long-term testosterone therapy, and neither was mentioned in the video.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- This creator stopped testosterone after approximately five years of use, reporting physical changes consistent with declining androgen levels, including softer skin and reduced facial hair density, while retaining permanent virilizing changes such as voice depth and altered fat distribution. Cessation of exogenous testosterone in individuals with ovaries may eventually restore endogenous hormonal cycling, but the timeline and completeness of that restoration vary by individual and duration of prior T use. Bone density monitoring and mental health support are clinically relevant considerations when discontinuing long-term testosterone therapy, and neither was mentioned in the video.
- Bustos et al. (2021) found roughly 1% regret rates for gender-affirming surgeries, genuinely lower than many elective procedures, but follow-up attrition in these studies is a known methodological limitation.
- Stopping testosterone after long-term use does not guarantee a return to prior hormonal baselines. Grimstad et al. (2021, Journal of Pediatric and Adolescent Gynecology) document significant individual variability in resumption of endogenous cycling.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Bustos et al. (2021) found roughly 1% regret rates for gender-affirming surgeries, genuinely lower than many elective procedures, but follow-up attrition in these studies is a known methodological limitation.
- Stopping testosterone after long-term use does not guarantee a return to prior hormonal baselines. Grimstad et al. (2021, Journal of Pediatric and Adolescent Gynecology) document significant individual variability in resumption of endogenous cycling.
- Some testosterone-induced changes, including voice deepening and clitoral enlargement, are largely permanent regardless of cessation. Facial and body hair may thin but often does not fully disappear.
- Testosterone therapy carries documented medical risks including polycythemia and lipid changes (Irwig, 2017). Gender-affirming care has strong psychological benefit evidence, but blanket claims of zero risk are not supported.
- Turban et al. (2021, JAMA Network Open) document that gender identity and expression can continue evolving after medical transition, which supports the creator's framing of ongoing gender exploration as a recognized experience.
- Bone density should be assessed when discontinuing long-term testosterone, particularly if the individual is not replacing with another hormone. This was not mentioned in the video and is a clinically relevant gap.
- Emotional difficulty during hormone changes, which this creator acknowledged, is documented and expected. Mental health support from a provider familiar with gender care is a practical resource, not optional.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
august 💌 · TikTok creator
183.0K views on this video
re-coming out / gender stuff / retransition vs detransition #transgender #nonbinary #genderfluid #ftm #mtf
Sources & references
- [1]Bustos et al. (2021)
- [2]Bourne et al., 2010
- [3]Miesen et al. (2018)
- [4]Turban et al., 2021
- [5]Grimstad et al., 2021
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by august 💌, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.